Is chromium a trace essential metal?

BioFactors

Volumn 11, Issue 3, 2000, Pages 149-162

  Stearns, Diane M ^a  

^a NORTHERN ARIZONA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; TRACE METAL;

CANCER; CHEMICAL ANALYSIS; GLUCOSE TOLERANCE; IRON ABSORPTION; MOLECULAR WEIGHT; PRIORITY JOURNAL; REVIEW; TOTAL PARENTERAL NUTRITION;

ANIMALIA;

EID: 0034042877     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520110301     Document Type: Review

References (124)

1. Inorganic Biochemistry: An Introduction, J.A. Cowan, ed., VCH Publisher, Inc., New York, 1993.
2. W. Mertz, Chromium in human nutrition: a review, J. Nutr. 123 (1993), 626-633.
3. W. Mertz and K. Schwarz, Impaired intravenous glucose tolerance as an early sign of dietary necrotic liver degeneration Arch. Biochem. Biophys. 58 (1955), 504-506.
4. K. Schwarz and W. Mertz, A glucose tolerance factor and its differentiation from Factor 3, Arch. Biochem. Biophys. 72 (1957), 515-518.
5. K. Schwarz and W. Mertz, Chromium(III) and the glucose tolerance factor, Arch. Biochem. Biophys. 85 (1959), 292-295.
6. W. Mertz, E.W. Toepfer, E.E. Roginski and M.M. Polansky, Present knowledge of the role of chromium, Federation Proc. 33 (1974), 2275-2280.
7. E. W. Toepfer, W. Mertz, M.M. Polansky, E.E. Roginski and W.R. Wolf, Preparation of chromium-containing material of glucose tolerance factor activity from Brewer's yeast extracts and by synthesis, J. Agric. Food Chem. 25 (1977), 162-166.
8. R.A. Anderson, Essentiality of chromium in humans, Sci. Total Environ. 86 (1989), 75-81.
9. W. Mertz, Chromium occurrence and function in biological systems, Phys. Rev. 49 (1969), 163-239.
10. M. Simonoff, Chromium deficiency and cardiovascular risk, Cardiovascular Res. 18 (1984), 591-596.
11. R.A. Anderson, Chromium metabolism and its role in disease processes in man, Clin. Physiol. Biochem. 4 (1986), 31-41.
12. R.A. Anderson, Chromium and parenteral nutrition, Nutrition 11 (1995), 83-86.
13. Nutrition Advisory Group, American Medical Association, Guidelines for essential trace element preparations for parenteral use, JAMA 241 (1979), 2051-2054.
14. C.R. Fleming, Trace element metabolism in adult patients requiring total parenteral nutrition, Am. J. Clin. Nutr. 49 (1989), 573-579.
15. F.Y. Leung and L.V. Galbraith, Elevated serum chromium in patients on total parenteral nutrition and the ionic species of contaminant chromium, Biol. Trace Elem. Res. 50 (1995), 221-228.
16. F.Y. Leung, Trace elements in parenteral micronutrition, Clinical Biochem. 28 (1995), 561-566.
17. K.N. Jeejeebhoy, R.C. Chu, E.B. Marliss, G.R. Greenberg and A. Bruce-Robertson, Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition, Am. J. Clin. Nutr. 30 (1977), 531-538.
18. H. Freund, S. Atamian and J.F. Fischer, Chromium deficiency during total parenteral nutrition, JAMA 241 (1979), 496-498.
19. R.O. Brown, S. Forloines-Lynn, R.E. Cross and W.D. Heizer, Chromium deficiency after long-term total parenteral nutrition, Dig. Dis. Sci. 31 (1986), 661-664.
20. Anonymous, Is chromium essential for humans?, Nutr. Rev. 46 (1988), 17-20.
21. K. Tsuda, Y. Yokoyama, M. Morita, Y. Nakazawa and S. Onishi, Selenium and chromium deficiency during long-term home total parenteral nutrition in chronic idiopathic intestinal pseudoobstruction, Nutrition 14 (1998), 291-295.
22. R.A. Anderson, J.S. Borel, M.M. Polansky, N.A. Bryden, TC. Majerus and PB. Moser, Chromium intake and excretion of patients receiving total parenteral nutrition: effects of supplemental chromium, J. Trace Elem. Exper. Med. 1 (1988), 9-18.
23. M. Costa, Toxicity and carcinogenicity of Cr(VI) in animal models and humans, Crit. Rev. Toxicol. 27 (1997), 431-442.
24. R.A. Anderson, J.H. Brantner and M.M. Polansky, An improved assay for biologically active chromium, J. Agric. Food Chem. 26 (1978), 1219-1221.
25. 51Cr complex from Brewer's yeast, Biochem. Biophys. Res. Commun. 55 (1973), 312-319.
26. J. Kumpulainen, P. Koivistoinen and S. Lahtinen, Isolation, purification and partial chemical characterization of chromium(III) fractions existing in Brewer's yeast and Sabouraud's liquid medium, Bioinorg. Chem. 8 (1978), 419-429.
27. N. Mirsky, A. Weiss and Z. Dori, Chromium in biological systems, I. Some observations on glucose tolerance factor in yeast, J. Inorg. Biochem. 13 (1980), 11-21.
28. S. J. Haylock, R.J. Thornton, P.D. Buckley and L.F. Blackwell, Effect of chromium on the rate of carbon dioxide evolution from Saccharomyces cerevisiae, Exp. Mycol. 6 (1982), 335-344.
29. S.J. Haylock, P.D. Buckley and L.F. Blackwell, Separation of biologically active chromium-containing complexes from yeast extracts and other sources of glucose tolerance factor activity, J. Inorg. Biochem. 18 (1983), 195-211.
30. A. Khan, N.A. Bryden, MM. Polansky and R.A. Anderson, Insulin potentiating factor and chromium content of selected foods and spices, Biol. Trace Elem. Res. 24 (1990), 183-188.
31. E.S. Holdsworth and E. Neville, Effects of extracts of high- and low-chromium Brewer's yeast on metabolism of glucose by hepatocytes from rats fed on high-or low-Cr diets, Brit. J. Nutr. 63 (1990), 623-630.
32. M. Simonoff, D. Shapcott, S. Alameddine, M.T. Sutter-Dub and G. Simonoff, The isolation of glucose tolerance factors from Brewer's yeast and their relation to chromium, Biol. Trace Elem. Res. 32 (1992), 25-38.
33. S.J. Haylock, P.D. Buckley and L.F Blackwell, The relationship of chromium to the glucose tolerance factor. II, J. Inorg. Biochem. 19 (1983), 105-117.
34. D.L. Hwang, A. Lev-Ran, T. Papoian and W.K. Beech, Insulin-like activity of chromium-binding fractions from Brewer's yeast, J. Inorg. Biochem. 30 (1987), 219-225.
35. T. Urumow and O.H. Wieland, On the nature of the glucose tolerance factor from yeast, Horm. Metab. Res. 16(Suppl.) (1984), 51-54.
36. D.M. Davies, E.S. Holdsworth and J.L. Sherriff, The isolation of glucose tolerance factors from Brewer's yeast and their relationship to chromium, Biochem. Med. 33 (1985), 297-311.
37. E.M. O'Donoghue, J.A. Cooper, T.G. Jackson, P.R. Shepherd, P.D. Buckley and L.F. Blackwell, Identification of peptides from autolysates of Saccharomyces cerevisiae that exhibit glucose tolerance factor activity in a yeast assay, Int. J. Biochem. 22 (1990), 841-846.
38. Y. Fischer, J. Thomas, H. Rose and H. Kammermeier, Alanine and hyperosmolarity are responsible for the stimulation of cardiomyocyte glucose transport by samples containing a glucose tolerance factor, Life Sci. 50 (1992), 1963-1972.
39. W. Mertz, E.E. Roginski and K. Schwarz, Effect of trivalent chromium complexes on glucose uptake by epididymal fat tissue of rats, J. Biol. Chem. 236 (1961), 318-322.
40. A. Yamamoto, O. Wada, T. Ono, H. Ono, S. Manabe and S. Ishikawa, Cadmium-induced stimulation of lipogenesis from glucose in rat adipocytes, Biochem. J. 219 (1984), 979-984.
41. Y. Goto and K. Kida, Insulin-like action of chromate on glucose transport in isolated rat adipocytes, Jpn. J. Pharmacol. 67 (1995), 365-368.
42. C.A. Pasternak, Transmembrane communication and disease, Ind. J. Biochem. Biophys. 27 (1990), 363-364.
43. G.W. Evans, E.E. Roginski and W. Mertz, Interaction of the glucose tolerance factor (GTF) with insulin, Biochem. Biophys. Res. Commun. 50 (1973), 718-722.
44. G.W. Evans and T.D. Bowman, Chromium picoinate increases membrane fluidity and rate of insulin internalization, J. Inorg. Biochem. 46 (1992), 243-250.
45. K.H. Sumrall and J.B. Vincent, Is glucoses tolerance factor an artifact produced by acid hydrolysis of low-molecular-weight chromium-binding substance?, Polyhedron 16 (1997), 4171-4177.
46. A. Yamamoto, O. Wada and T. Ono, A low-molecular-weight, chromium-binding substance in mammals, Toxicol. Appl. Pharmacol. 59 (1981), 515-523.
47. O. Wada, G.Y. Wu, A. Yamamoto, S. Manabe and T. Ono, Purification and chromium-excretory function of low-molecular weight, chromium-binding substances from dog liver, Environ. Res. 32 (1983), 228-239.
48. A. Yamamoto, O. Wada and T. Ono, Distribution and chromium-binding capacity of a low-molecular-weight, chromium-binding substance in mice, J. Inorg. Biochem. 22 (1984), 91-102.
49. A. Yamamoto, O. Wada and T. Ono, Isolation of a biologically active low-molecular-mass chromium compound from rabbit liver, Eur. J. Biochem. 165 (1987), 627-631.
50. A. Yamamoto, O. Wada and H. Suzuki, Purification and properties of biologically active chromium complex from bovine colostrum, J. Nutr. 118 (1988), 39-45.
51. C.M. Davis and J.B. Vincent, Isolation and characterization of a biologically active chromium oligopeptide from bovine liver, Arch. Biochem. Biophys. 339 (1997), 335-343.
52. A. Yamamoto, O. Wada and S. Manabe, Evidence that chromium is an essential factor for biological activity of low-molecular-weight, chromium-binding substance, Biochem. Biophys. Res. Commun. 163 (1989), 189-193.
53. J.B. Vincent, Mechanisms of chromium action: low-molecular-weight chromium-binding substance, J. Am. Coll. Nutr. 18 (1999), 6-12.
54. E.J. Yurkow and G. Kim, Effects of chromium on basal and insulin-induced tyrosine phosphorylation in H4 hepatoma cells: comparison with phorbol-12-myristate-13-acetate and sodium orthovanadate, Molec. Pharmacol. 47 (1995), 686-695.
55. H. Huang, C.F. Huang, D.R. Wu, C.M. Jinn and K.Y. Jan, Glutathione as a cellular defence against arsenite toxicity in cultured Chinese hamster ovary cells, Toxicology 79 (1993), 195-204.
56. C.A. Burton, K. Hatlelid, K. Divine, D.E. Carter, Q. Fernando, K. Brendel and A.J. Gandolfi, Glutathione effects on toxicity and uptake of mercuric chloride and sodium arsenite in rabbit renal cortical slices, Environ. Health Perspect. 103(Suppl. 1) (1995), 81-84.
57. B.A. Fowler, Roles of lead-binding proteins in mediating lead bioavailability, Environ. Health Perspect. 106(Suppl. 6) (1998), 1585-1587.
58. G. DuVal and B.A. Fowler, Preliminary purification and characterization studies of a low molecular weight, high affinity cytosolic lead-binding protein in rat brain, Biochem. Biophys. Res. Commun. 159 (1989), 177-184.
59. Y.J. Kang, Exogenous glutathione decreases cellular cadmium uptake and toxicity, Drug. Metab. Dispos. 20 (1992), 714-718.
60. C.D. Klaassen, J. Liu and S. Choudhuri, Metallothionein: an intracellular protein to protect against cadmium toxicity, Annu. Rev. Pharmacol. Toxicol. 39 (1999), 267-294.
61. M.P. Waalkes, S. Rehm and A. Perantoni, Metal-biding proteins of the Syrian hamster ovaries: apparent deficiency of metallothionein, Biol. Reproduc. 39 (1988), 953-961.
62. P.D. Whanger, J.T. Deagen and M.A. Beilstein, Low molecular weight cadmium and selenium containing proteins unlike metallothionein in animals, Experientia Suppl. 52 (1987), 281-286.
63. S. Langård, One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports, Am. J. Indust. Med. 17 (1990), 189-215.
64. IARC, Chromium and chromium compounds, in: Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Chromium, Nickel and Welding, International Agency for Research on Cancer, Lyon, 1990, pp. 49-256.
65. M.D. Cohen, B. Kargacin, C.B. Klein and M. Costa, Mechanisms of chromium carcinogenicity and toxicity, Crit. Rev. Toxicol. 23 (1993), 255-281.
66. E.T. Snow, Metal carcinogenesis: mechanistic implications, Pharmac. Ther. 53 (1992), 31-65.
67. S. De Flora and K.E. Wetterhahn, Mechanisms of chromium metabolism and genotoxicity, Life Chem. Reports 7 (1989), 169-244.
68. K. Wetterhahn Jennette, Chromate metabolism in liver microsomes, Biol. Trace Elem. Res. 1 (1979), 55-62.
69. T.F. Mancuso, Chromium as an industrial carcinogen: Part 1, Am. J. Ind. Med. 31 (1997), 129-139.
70. S. De Flora, M. Bagnasco, D. Serra and P. Zanacchi, Genotoxicity of chromium compounds. A review, Mutat. Res. 238 (1990), 99-172.
71. A.G. Levis and F. Majone, Cytotoxic and clastogenic effects of soluble chromium compounds on mammalian cell cultures, Br. J. Cancer 40 (1979), 523-533.
72. Z. Elias, O. Schneider, F. Aubry, M.C. Daniere and O. Poirot, Sister chromatid exchanges in Chinese hamster V79 cells treated with the trivalent chromium compounds chromic chloride and chromic oxide, Carcinogenesis 4 (1983), 605-611.
73. P. Venier, A. Montaldi, L. Busi, C. Gava, L. Zentilin, G. Tecchio, V. Bianchi and A.G. Levis, Genetic effects of chromium tannins, Carcinogenesis 6 (1985), 1327-1335.
74. A. Kortenkamp, D. Beyersmann and P. O'Brien, Uptake of chromium(III) complexes by erythrocytes, Toxicol. Environ. Chem. 14(1987), 23-32.
75. C.L. Gava, L. Perazzolo, L. Zentilin, A.G. Levis, B. Corain, G.G. Bombi, M. Palumbo and P. Zatta, Genotoxic potentiality and DNA binding properties of acetylacetone, maltol and their aluminium(III) and chromium(III) neutral complexes, Toxicol. Environ. Chem. 22 (1989), 149-157.
76. G. Warren, P. Schultz, D. Bancroft, K. Bennett, E.H. Abbott and S. Rogers, Mutagenicity of a series of hexacoordinate chromium(III) compounds, Mutat Res. 90 (1981), 111-118.
77. 3+ complexes, Biochemistry 31 (1992), 11 626-11 631.
78. D. Beyersmann and A. Köster, On the role of trivalent chromium in chromium genotoxicity, Toxicol. Environ. Chem. 14 (1987), 11-22.
79. D.M. Stearns, J.P. Wise, Sr., S.R. Patierno and K.E. Wetterhahn, Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells, FASEB J. 9 (1995), 1643-1649.
80. A.J. Fornace, Jr., D.S. Seres, J.F. Lechner and C.C. Harris, DNA-protein cross-linking by chromium salts, Chem.-Biol. Interactions 36 (1981), 345-354.
81. L.C. Bridgewater, F.C.R. Manning, E.S. Woo and S.R. Patierno, DNA polymerase arrest by adducted trivalent chromium, Mol. Carcinog. 9 (1994), 122-133.
82. L.C. Bridgewater, F.C.R. Manning and S.R. Patierno, Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking, Carcinogenesis 15 (1994), 2421-2427.
83. E.T. Snow, Effects of chromium on DNA replication in vitro, Environ. Health Perspect. 102(Suppl. 3) (1994), 41-44.
84. A. Kortenkamp, P. O'Brien and D. Beyersmann, The reduction of chromate is a prerequisite of chromium binding to cell nuclei, Carcinogenesis 12 (1991), 1143-1144.
85. A.S. Hneihan, A.M. Standeven and K.E. Wetterhahn, Differential binding of chromium(VI) and chomium(III) complexes to salmon sperm nuclei and nuclear DNA and isolated calf thymus DNA, Carcinogenesis 14 (1993), 1795-1803.
86. J.K. Speetjens, R.A. Collins, J.B. Vincent and S.A. Woski, The nutritional supplement chromium(III) tris(picolinate) cleaves DNA, Chem. Res. Toxicol. 12 (1999), 483-487.
87. T.-C. Tsou, R.-J. Lin and J.-L. Yang, Mutational spectrum induced by chromium(III) in shuttle vectors replicated in human cells: relationship to Cr(III)-DNA interactions, Chem. Res. Toxicol. 10 (1997), 962-970.
88. V. Voitkun, A. Zhitkovich and M. Costa, Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells, Nucleic Acids Res. 26 (1998), 2024-2030.
89. W. Mertz, Chromium research from a distance: from 1959 to 1980, J. Am. Coll. Nutr. 17 (1998), 544-547.
90. R.A. Anderson, Recent advances in the clinical and biochemical effects of chromium deficiency, in: Essential and Toxic Trace Elements in Human Health and Disease: An Update, A.S. Prasad, ed., Wiley-Liss, New York, 1993, pp. 221-234.
91. V.W. Bunker, M.S. Lawson, H.T. Delves and B.E. Clayton, The uptake and excretion of chromium by the elderly, Am. J. Clin. Nutr. 39 (1984), 797-802.
92. R.A. Anderson and A.S. Kozlovsky, Chromium intake, absorption and excretion of subjects consuming self-selected diets, Am. J. Clin. Nutr. 41 (1985), 1177-1183.
93. E.G. Offenbacher, H. Spencer, H.J. Dowling and F.X. Pi-Sunyer, Metabolic chromium balances in men, Am. J. Clin. Nutr. 44 (1986), 77-82.
94. R.A. Anderson, N.A. Bryden and M.M. Polansky, Dietary intake of calcium, chromium, copper, iron, magnesium, manganese, and zinc: duplicate plate values corrected using derived nutrient intake, J. Am. Diet. Assoc. 93 (1993), 462-464.
95. J.R. Turnlund, Future directions for establishing mineral/trace element requirements, J. Nutr. 124 (1994), 1765S-1770S.
96. F.H. Nielsen, Chromium, in: Modern Nutrition in Health and Disease, 8th edn, Vol. 1, M.E. Shils, J.A. Olson and M. Shike, eds, Lea & Febiger, Philadelphia, 1994, pp. 264-268.
97. H.A. Schroeder, J.J. Balassa and I.H. Tipton, Abnormal trace metals in man - chromium, J. Chron. Dis. 15 (1962), 941-964.
98. J. Versieck, Trace elements in human body fluids and tissues, CRC Crit. Rev. Clin. Sci. 22 (1985), 97-184. Chromium values are summarized on pp. 101 (standards), 121-123 and 133-134 (in urine), 125-126 (in plasma and serum), 139 (in lung), 144 (in liver), 156 (in kidney), 160 (in muscle).
99. E. Vuori and J. Kumpulainen, A new low level of chromium in human liver and spleen, Trace Elem. Med. 4 (1987), 88-91.
100. B.C. Shah and B. Belonje, Levels of magnesium, copper, chromium, manganese and cadmium in the livers of Canadians, Trace Elem. Med. 7 (1990), 11-18.
101. T.D.B. Lyon and G.S. Fell, Trace elements in autopsy tissue, Food Chem. 43 (1992), 299-306.
102. M. Anderson, D. Riley and J. Rotruck, Chromium tris-acetylacetonate: an absorbable, bioactive source of chromium, Fed. Proc. 39 (1980), Abstract 2753.
103. 51Cr picolinate in a rat model, Trace Elem. Electrol. 11 (1994), 182-186.
104. M.L. Gargas, R.L. Norton, D.J. Paustenbach and B.L. Finley, Urinary excretion of chromium by humans following ingestion of chromium picolinate: implications for biomonitoring, Drug Metab. Dispos. 22 (1994), 522-529.
105. R.A. Anderson, M.M. Polansky, N.A. Bryden, K.Y. Patterson, C. Veillon and W.H. Glinsmann, Effects of chromium supplementation on urinary Cr excretion of human subjects and correlations of Cr excretion with selected clinical parameters, J. Nutr. 113 (1983), 276-281.
106. H.C. Lukaski, W.W. Bolonchuk, W.A. Siders and D.B. Milne, Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men, Am. J. Clin. Nutr. 63 (1996), 954-965.
107. D.M. Stearns, J.J. BelBruno and K.E. Wetterhahn, A prediction of Cr(III) accumulation in humans from ingestion of Cr dietary supplements, FASEB J. 9 (1995), 1650-1657.
108. Y. Ishikawa, K. Nakagawa, Y. Satoh, T. Kitagawa, H. Sugano, T. Hirano and E. Tsuchiya, Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study, Br. J. Cancer 70 (1994), 160-166.
109. T.F. Mancuso, Chromium as an industrial carcinogen: Part 2. Chromium in human tissues, Am. J. Ind. Med. 31 (1997), 140-147.
110. A. Aitio, J. Järvisalo, M. Kiilunen, A. Tossavainen and P. Vaittinen, Urinary excretion of chromium as an indicator of exposure to trivalent chromium sulphate in leather tanning, Intl. Arch. Environ. Health 54 (1984), 241-249.
111. N.A. Lee and C.A. Reasner, Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM, Diabetes Care 17 (1994), 1449-1452.
112. D. Brune, A. Aitio, G. Nordberg, O. Vesterberg and L. Gerhardsson, Normal concentrations of chromium in serum and urine - a TRACY project, Scand. J. Work Environ. Health 19(Suppl.) (1993), 39-44.
113. J.A. Randall and R.S. Gibson, Serum and urine chromium as indices of chromium status in tannery workers, Proc. Soc. Exp. Biol. Med. 185 (1987), 16-23.
114. B.L. Finley, P.K. Scott, R.L. Norton, M.L. Gargas and D.J. Paustenbach, Urinary chromium concentrations in humans following ingestion of safe doses of hexavalent and trivalent chromium: Implications for biomonitoring, J. Toxicol. Environ. Health 48 (1996), 479-499.
115. Advanced Inorganic Chemistry, F.A. Cotton and G. Wilkinson, eds, John Wiley & Sons, Inc., New York, 1988, p. 1388.
116. D.C. Harris, Different metal-binding properties of the two sites of human transferrin, Biochemistry 16 (1977), 560-564.
117. A.A. Moshtaghie, M. Ani and M.R. Bazrafshan, Comparative binding study of aluminum and chromium to human transferrin. Effect of iron, Biol. Trace Elem. Res. 32 (1992), 39-46.
118. M. Ani and A.A. Moshtaghie, The effect of chromium on parameters related to iron metabolism, Biol. Trace Elem. Res. 32 (1992), 57-64.
119. R.A. Anderson, N.A. Bryden, M.M. Polansky and K. Gautschl, Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats, J. Trace Elem. Exp. Med. 9 (1996), 11-25.
120. D. Bougle, F. Bureau, G. Deschrevel, C. Hecquard, D. Neuville, M. Drosdowsky and J.F. Duhamel, Chromium and parenteral nutrition in children, J. Pediatr. Gastroent. Nutr. 17 (1993), 72-74.
121. J.T. Salonen, T.-P. Tuomainen, K. Nyyssönen, H.-M. Lakka and K. Punnonen, Relation between iron stores and non-insulin-dependent diabetes in men: case-control study, Brit. Med. J. 317 (1998), 727.
122. R.D. Crawford, Proposed role for a combination of citric acid anad ascorbic acid in the production of dietary iron overload: a fundamental cause of disease, Biochem. Mol. Med. 54 (1995), 1-11.
123. R.A. Anderson, N.A. Bryden, M.M. Polansky and K. Gautschl, Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats, J. Trace Elem. Exp. Med. 9 (1996), 11-25.
124. P.R. Shepherd, C. Elwood, P.B. Buckley and L.F. Blackwell, Glucose tolerance factor potentiation of insulin action in adipocytes from rats raised on a Torula yeast diet cannot be attributed to a deficiency of chromium or glucose tolerance factor activity in the diet, Biol. Trace Elem. Res. 32 (1992), 109-113.